KOMIPHARM INTERNATIONAL CO., LTD

KOMIPHARM INTERNATIONAL CO., LTD

KOMIPHARM was founded in 1972 and is engaged in the research and manufacturing of veterinary vaccines and pharmaceuticals, as well as serum testing, bacterial isolation, genetic testing and virus isolation. In addition, it has been recognized as a venture company, an INNO-BIZ(Innovative) company, and a technology evaluation company in recognition of its technology for manufacturing vaccines. In the 21st century, experts predict that the bio-industry sector will come to the forefront of the nation’s wealth. In order to grow into a global company in line with the current trends, we are developing vaccines using genetic engineering and recombinant technology and an animal disease diagnosis center for prompt and accurate disease diagnosis. In the human medicine business, we are concentrating our efforts on the development of an anti-cancer drug called “KOMINOX” which can treat patients without the side effects by directly attacking telomere of cancer cells and removing cancer genes, and developing cancer pain medicine